Thomson Reuters decides to stay in healthcare game

Thomson Reuters has shelved plans to sell its healthcare division due to economic conditions that will prevent the company from receiving what the company believes is a fair value for its profitable business.

The New York City-based company will wait until an economic climate more conducive to a divestiture develops to complete a sale, according to a Dec. 22, 2011 statement.

The unit had revenues of approximately $450 million in 2010; however, Thomson Reuters had been planning on selling its healthcare division since June 2011.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup